Cas 863784-27-4,3-(5-Methyl-thieno[2,3-d]pyrimidin-4-yloxy)-2-phenyl-[1,8]naphthyridine

863784-27-4

Post Buying Request

Basic information

Product Name: 3-(5-Methyl-thieno[2,3-d]pyrimidin-4-yloxy)-2-phenyl-[1,8]naphthyridine
Synonyms: 3-(5-Methyl-thieno[2,3-d]pyrimidin-4-yloxy)-2-phenyl-[1,8]naphthyridine
CAS NO:863784-27-4
Molecular Formula:
Molecular Weight: 370.434
EINECS: N/A
Product Categories: N/A
Mol File: 863784-27-4.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(5-Methyl-thieno[2,3-d]pyrimidin-4-yloxy)-2-phenyl-[1,8]naphthyridine(CAS DataBase Reference)
NIST Chemistry Reference: 3-(5-Methyl-thieno[2,3-d]pyrimidin-4-yloxy)-2-phenyl-[1,8]naphthyridine(863784-27-4)
EPA Substance Registry System: 3-(5-Methyl-thieno[2,3-d]pyrimidin-4-yloxy)-2-phenyl-[1,8]naphthyridine(863784-27-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 863784-27-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

863784-27-4 Suppliers

Recommended suppliersmore

863784-27-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 863784-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,7,8 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 863784-27:
(8*8)+(7*6)+(6*3)+(5*7)+(4*8)+(3*4)+(2*2)+(1*7)=214
214 % 10 = 4
So 863784-27-4 is a valid CAS Registry Number.

863784-27-4Upstream product

863784-27-4Downstream Products

863784-27-4Relevant articles and documents

COMPOUND HAVING TGF-BETA INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

-

Page/Page column 66, (2010/11/24)

The present invention provides compounds of formula (I) or compounds of formula (II) and pharmaceutically acceptable salts or solvates thereof. An objective of the present invention is to provide compounds having TGF2 inhibitory activity.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 863784-27-4